Matilda Florentin

2.3k total citations
73 papers, 1.7k citations indexed

About

Matilda Florentin is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Matilda Florentin has authored 73 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Surgery, 27 papers in Endocrinology, Diabetes and Metabolism and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Matilda Florentin's work include Lipoproteins and Cardiovascular Health (27 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers) and Pharmacology and Obesity Treatment (10 papers). Matilda Florentin is often cited by papers focused on Lipoproteins and Cardiovascular Health (27 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers) and Pharmacology and Obesity Treatment (10 papers). Matilda Florentin collaborates with scholars based in Greece, United Kingdom and United States. Matilda Florentin's co-authors include Moses Elisaf, Evangelos Liberopoulos, Dimitri P. Mikhailidis, Anthony S. Wierzbicki, Michael S. Kostapanos, Dimitri P. Mikhailidis, Haralampos Milionis, Georgé Liamis, Vasilios G. Athyros and Sotirios Giannopoulos and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Nutrients.

In The Last Decade

Matilda Florentin

68 papers receiving 1.7k citations

Peers

Matilda Florentin
Matilda Florentin
Citations per year, relative to Matilda Florentin Matilda Florentin (= 1×) peers Zorana Jelić‐Ivanović

Countries citing papers authored by Matilda Florentin

Since Specialization
Citations

This map shows the geographic impact of Matilda Florentin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matilda Florentin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matilda Florentin more than expected).

Fields of papers citing papers by Matilda Florentin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matilda Florentin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matilda Florentin. The network helps show where Matilda Florentin may publish in the future.

Co-authorship network of co-authors of Matilda Florentin

This figure shows the co-authorship network connecting the top 25 collaborators of Matilda Florentin. A scholar is included among the top collaborators of Matilda Florentin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matilda Florentin. Matilda Florentin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arvanitakis, Konstantinos, Georgios Kalopitas, Matilda Florentin, et al.. (2025). Hepatic Iron Overload and Hepatocellular Carcinoma: New Insights into Pathophysiological Mechanisms and Therapeutic Approaches. Cancers. 17(3). 392–392. 5 indexed citations
2.
Nikas, Dimitrios, et al.. (2025). Structural radial artery modifications following transradial access: Mechanisms, clinical implications, and preventive strategies. World Journal of Cardiology. 17(7). 107772–107772.
3.
Florentin, Matilda, et al.. (2024). Association of Alkaline Phosphatase with Cardiovascular Disease in Patients with Dyslipidemia: A 6-Year Retrospective Study. Journal of Cardiovascular Development and Disease. 11(2). 60–60.
4.
Liamis, Georgé, et al.. (2023). Effects of Lipid-Modifying and Other Drugs on Lipoprotein(a) Levels—Potent Clinical Implications. Pharmaceuticals. 16(5). 750–750. 14 indexed citations
5.
Anagnostis, Panagiotis, Christina Antza, Matilda Florentin, & Vasilios Kotsis. (2023). Familial hypercholesterolemia and its manifestations: Practical considerations for general practitioners. Kardiologia Polska. 81(11). 1081–1088. 3 indexed citations
6.
Kouvari, Matina, Matilda Florentin, Rena I. Kosti, et al.. (2022). Egg Consumption, Cardiovascular Disease and Cardiometabolic Risk Factors: The Interaction with Saturated Fatty Acids. Results from the ATTICA Cohort Study (2002–2012). Nutrients. 14(24). 5291–5291. 8 indexed citations
8.
Kostapanos, Michael S., Matilda Florentin, Moses Elisaf, & Dimitri P. Mikhailidis. (2014). Hemostatic Factors and the Metabolic Syndrome. Current Vascular Pharmacology. 11(6). 880–905. 39 indexed citations
9.
Lioudaki, Eirini, Matilda Florentin, Emmanuel S. Ganotakis, & Dimitri P. Mikhailidis. (2013). Microalbuminuria: A Neglected Cardiovascular Risk Factor in Non-diabetic Individuals?. Current Pharmaceutical Design. 19(27). 4964–4980. 8 indexed citations
10.
Florentin, Matilda, Evangelos Liberopoulos, Christos V. Rizos, et al.. (2012). Colesevelam Plus Rosuvastatin 5 mg/Day Versus Rosuvastatin 10 mg/Day Alone on Markers of Insulin Resistance in Patients with Hypercholesterolemia and Impaired Fasting Glucose. Metabolic Syndrome and Related Disorders. 11(3). 152–156. 12 indexed citations
11.
Florentin, Matilda, et al.. (2011). Antiplatelet Drugs: What Comes Next?. UCL Discovery (University College London). 1 indexed citations
12.
Mikhailidis, Dimitri P., Moses Elisaf, Manfredi Rizzo, et al.. (2011). “European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses. Current Vascular Pharmacology. 9(5). 533–571. 156 indexed citations
13.
Florentin, Matilda, Evangelos Liberopoulos, Elisavet Moutzouri, et al.. (2011). The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia. Current Medical Research and Opinion. 27(3). 685–692. 23 indexed citations
14.
Florentin, Matilda, Evangelos Liberopoulos, Dimitri P. Mikhailidis, & Moses Elisaf. (2011). Emerging options in the treatment of dyslipidemias: a bright future?. Expert Opinion on Emerging Drugs. 16(2). 247–270. 12 indexed citations
15.
Anagnostis, Panagiotis, Vasilios G. Athyros, Fotini Adamidou, Matilda Florentin, & Asterios Karagiannis. (2010). Vitamin D and Cardiovascular Disease: A Novel Agent for Reducing Cardiovascular Risk?. Current Vascular Pharmacology. 8(5). 720–730. 48 indexed citations
16.
Florentin, Matilda, et al.. (2010). Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia. Current Vascular Pharmacology. 8(6). 820–830. 25 indexed citations
17.
Liberopoulos, Evangelos, Matilda Florentin, Kostas C. Siamopoulos, & Moses Elisaf. (2009). A patient with new-onset hypercholesterolemia. Journal of clinical lipidology. 3(2). 143–145. 1 indexed citations
18.
Florentin, Matilda, Evangelos Liberopoulos, D.P. Mikhailidis, & Moses Elisaf. (2008). Sitagliptin in clinical practice: a new approach in the treatment of type 2 diabetes. Expert Opinion on Pharmacotherapy. 9(10). 1705–1720. 19 indexed citations
19.
Florentin, Matilda, Evangelos Liberopoulos, Theodosios D. Filippatos, et al.. (2008). Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot study. Expert Opinion on Pharmacotherapy. 9(16). 2741–2750. 12 indexed citations
20.
Karagiannis, Asterios, Dimitri P. Mikhailidis, Vasilios G. Athyros, et al.. (2007). The role of renin–angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?. Expert Opinion on Therapeutic Targets. 11(2). 191–205. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026